Understanding Ciguatoxin-Induced CNS Depression and Evaluating Piperine as a Therapeutic Strategy †
Abstract
:Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Maurya, V.K. Understanding Ciguatoxin-Induced CNS Depression and Evaluating Piperine as a Therapeutic Strategy. Proceedings 2024, 103, 68. https://doi.org/10.3390/proceedings2024103068
Maurya VK. Understanding Ciguatoxin-Induced CNS Depression and Evaluating Piperine as a Therapeutic Strategy. Proceedings. 2024; 103(1):68. https://doi.org/10.3390/proceedings2024103068
Chicago/Turabian StyleMaurya, Vishesh Kumar. 2024. "Understanding Ciguatoxin-Induced CNS Depression and Evaluating Piperine as a Therapeutic Strategy" Proceedings 103, no. 1: 68. https://doi.org/10.3390/proceedings2024103068
APA StyleMaurya, V. K. (2024). Understanding Ciguatoxin-Induced CNS Depression and Evaluating Piperine as a Therapeutic Strategy. Proceedings, 103(1), 68. https://doi.org/10.3390/proceedings2024103068